Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Fondazione GISCAD (Gruppo Italiano per lo Studio dei Carcinomi dell'Apparato Digerente) is a prominent Italian non-profit research foundation dedicated to the advancement of clinical and translational research in gastrointestinal oncology. Established in 1992, the organization coordinates a vast network of oncology centers across Italy to design and execute multicenter clinical trials focusing on cancers of the digestive tract, including colorectal, gastric, and pancreatic malignancies. GISCAD's primary mission is to optimize therapeutic strategies and improve patient survival through independent, high-quality clinical research. The foundation frequently collaborates with academic institutions and pharmaceutical partners to evaluate novel drug combinations, targeted therapies, and the integration of molecular biomarkers into clinical practice. Their work is instrumental in defining new standards of care for gastrointestinal cancers within the European medical community.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Fondazione GISCAD.